Design and synthesis of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as PDE 4B inhibitors endowed with bronchodilator activity

被引：8
|
作者：
Abd El-Aleam, Rehab H. [1 ]
George, Riham F. [2 ]
Lee, Kevin J. [3 ]
Keeton, Adam B. [3 ]
Piazza, Gary A. [3 ]
Kamel, Amr A. [4 ]
El-Daly, Mahmoud E. [4 ]
Hassan, Ghaneya S. [2 ,5 ]
Abdel-Rahman, Hamdy M. [1 ,6 ]
机构：
[1] Nanda Univ, Fac Pharm, Pharmaceut Chem Dept, Bani Suwayf, Egypt
[2] Cairo Univ, Fac Pharm, Pharmaceut Chem Dept, Cairo 11562, Egypt
[3] Univ S Alabama, USA Mitchell Canc Inst, Drug Discovery Lab, Mobile, AL USA
[4] Minia Univ, Fac Pharm, Pharmacol & Toxicol Dept, El Minia, Egypt
[5] Badr Univ, Fac Pharm, Pharmaceut Chem Dept, Cairo, Egypt
[6] Assiut Univ, Fac Pharm, Med Chem Dept, Assiut, Egypt
来源：
ARCHIV DER PHARMAZIE | 2019年 / 352卷 / 08期
关键词：
1,2,4-triazolo[1,5-a]pyrimidine; bronchodilator activity; phosphodiesterase; 4B; ASTHMA; POTENT; ACTIVATION;
D O I：
10.1002/ardp.201900002
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of 1,2,4-triazolo[1,5-a]pyrimidine derivatives was designed, synthesized, and screened for their phosphodiesterase (PDE 4B) inhibitory activity and bronchodilation ability. Compound 7e showed 41.80% PDE 4B inhibition at 10 mu M. Eight compounds were screened for their bronchodilator activity, where compounds 7f and 7e elicited promising bronchodilator activity with EC50 values of 18.6 and 57.1 mu M, respectively, compared to theophylline (EC50 = 425 mu M). Molecular docking at the PDE 4B active site revealed a binding mode and docking scores comparable to those of a reference ligand, consistent with their PDE 4B inhibition activity.
引用
收藏
页数：11
相关论文
共 50 条
  • [41] Synthesis of New Pyrazolo[ 1,5-a]pyrimidine, Triazolo[ 4,3-a] pyrimidine Derivatives, and Thieno[ 2,3-b] pyridine Derivatives from Sodium 3-(5-Methyl-1-phenyl-1H-pyrazol-4-yl)-3-oxoprop-1-en-1-olate
    Abdelhamid, Abdou O.
    Gomha, Sobhi M.
    JOURNAL OF CHEMISTRY, 2013, 2013
  • [42] 1H-1,2,4-Triazolo-5-diazonium salts in the synthesis of novel [1,2,4]triazolo[1,5-c][1,2,4]benzotriazin-6-ols
    Mawlood, Mohammad N.
    Potapov, Andrei Yu
    Vandyshev, Dmitriy Yu
    Shikhaliev, Khidmet S.
    Potapov, Mikhail A.
    Ledenyova, Irina, V
    Kosheleva, Evgeniya A.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2019, 55 (11) : 1075 - 1079
  • [43] Design, Synthesis, and Evaluation of the Anticancer Properties of a Novel Series of Imidazolone Fused Pyrazolo[1,5-a]pyrimidine Derivatives
    Kumar, Ajeesh A. K.
    Bodke, Yadav D.
    Gowda, Ashwath N.
    Sambasivam, Ganesh
    Bhat, Kishore G.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2017, 54 (03) : 1904 - 1924
  • [44] Design, Synthesis, Neuroprotective and Antibacterial Activities of 1,2,4-Triazolo[3,4-b]1,3,4-thiadiazole Linked Thieno[2,3-d]pyrimidine Derivatives and In Silico Docking Studies
    Settypalli, Triloknadh
    Chunduri, Venkata Rao
    Kerru, Nagaraju
    Nallapaneni, Hari Krishna
    Chintha, Venkata Ramaiah
    Daggupati, Trinath
    Yeguvapalli, Suneetha
    Wudayagiri, Rajendra
    CHEMISTRYSELECT, 2019, 4 (05): : 1627 - 1634
  • [45] IMINOPHOSPHORANES IN HETEROCYCLIC SYNTHESIS: SYNTHESIS OF PYRAZOLO[1,5-a]PYRIMIDINES, IMIDAZO[1,2-b]PYRAZOLE AND PYRAZOLO[1,5-b][1,2,4]TRIAZINE DERIVATIVES VIA INTERMOLECULAR AZA-WITTIG REACTIONS
    Raslan, Mohamed
    Khalil, Mohamed
    Sayed, Samia Mohamed
    HETEROCYCLES, 2013, 87 (12) : 2567 - 2576
  • [46] Alkylation of [1,2,4]triazolo[1,5-a][1,3,5]triazin-7(3H)-ones
    Ul'yankina, Irina V.
    Zavodskaya, Anna V.
    Parfenov, Victor E.
    Gidaspov, Alexander A.
    Shiryaev, Andrey K.
    Selezneva, Eugenia V.
    Bakharev, Vladimir V.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2016, 52 (12) : 1054 - 1060
  • [47] Design, Synthesis, and Development of Pyrazolo[1,5-a]pyrimidine Derivatives as a Novel Series of Selective PI3Kδ Inhibitors: Part II-Benzimidazole Derivatives
    Stypik, Mariola
    Michalek, Stanislaw
    Orlowska, Nina
    Zagozda, Marcin
    Dziachan, Maciej
    Banach, Martyna
    Turowski, Pawel
    Gunerka, Pawel
    Zdzalik-Bielecka, Daria
    Stanczak, Aleksandra
    Kedzierska, Urszula
    Mulewski, Krzysztof
    Smuga, Damian
    Maruszak, Wioleta
    Gurba-Bryskiewicz, Lidia
    Leniak, Arkadiusz
    Pietrus, Wojciech
    Ochal, Zbigniew
    Mach, Mateusz
    Zygmunt, Beata
    Pieczykolan, Jerzy
    Dubiel, Krzysztof
    Wieczorek, Maciej
    PHARMACEUTICALS, 2022, 15 (08)
  • [48] Phosphodiesterase inhibitors. Part 6: Design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity
    Kojima, Akihiko
    Takita, Satoshi
    Sumiya, Tatsunobu
    Ochiai, Koji
    Iwase, Kazuhiko
    Kishi, Tetsuya
    Ohinata, Akira
    Yageta, Yuichi
    Yasue, Tokutaro
    Kohno, Yasushi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (19) : 5311 - 5316
  • [49] Reactivity of 2-amino[1,2,4]triazolo[1,5-D°]-pyrimidines with various saturation of the pyrimidine ring towards electrophiles
    Astakhov, Alexander V.
    Sokolov, Andrey N.
    Pyatakov, Dmitry A.
    Shishkina, Svetlana V.
    Shishkin, Oleg V.
    Chernyshev, Victor M.
    CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2015, 51 (11-12) : 1039 - 1047
  • [50] Facile Synthesis of New [1,2,4]Triazolo[4,3-b]pyridazine
    Arghiani, Z.
    Seyedi, S. M.
    Bakavoli, M.
    Eshghi, H.
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2015, 52 (04) : 1099 - 1107
12345